Interactions of heparin with human skin cells: Binding, location, and transdermal penetration

Journal of Biomedical Materials Research - Part A

Volumn 67, Issue 2, 2003, Pages 517-523

  Parisel, Claire ^a   Saffar, Line ^b   Gattegno, Liliane ^b   André, Valérie ^c   Abdul Malak, Nabil ^c   Perrier, Eric ^c   Letourneur, Didier ^a  

^a INSERM   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c France   (France)

Author keywords

Carbohydrate recognition; Cell binding; Heparin; Polysaccharide; Skin cells

Indexed keywords

CARBOHYDRATES; CELLS; DERMATOLOGY; DIFFUSION; SKIN; TISSUE;

TRANSDERMAL PENETRATION;

BIOMEDICAL ENGINEERING;

BETA N ACETYL DEXTRO GLUCOSAMINE 6 SULFATE; BIOMATERIAL; CHONDROITIN SULFATE; COSMETIC; DEXTRAN; FLUORESCEIN; HEPARIN; MEMBRANE RECEPTOR; POLYACRYLAMIDE; POLYHYDROXYETHYLACRYLAMIDE; POLYMER; POLYSACCHARIDE; SUGAR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL CULTURE; CELL INTERACTION; CELL SURFACE; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DERMIS; DIFFUSION; DRUG DELIVERY SYSTEM; EPIDERMIS; EPIDERMIS CELL; FIBROBLAST; FLOW CYTOMETRY; FLUORESCENCE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KERATINOCYTE; MELANOCYTE; MOLECULAR WEIGHT; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SKIN; SKIN CELL; SKIN PENETRATION; TISSUE ENGINEERING;

EID: 0346753839     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.10085     Document Type: Article

References (33)

1. Griffith LG, Naughton G. Tissue engineering-Current challenges and expanding opportunities. Science 2002;295:1009-1014.
2. Sefton MV, Woodhouse KA. Tissue engineering. J Cutan Med Surg 1998;3:18-23.
3. Boyce ST, Warden GD. Principles and practices for treatment of cutaneous wounds with cultured skin substitutes. Am J Surg 2002;183:445-456.
4. Machens HG, Berger AC, Mailaender P. Bioartificial skin. Cells Tissues Organs 2000;167:88-94.
5. Monsigny M. The role of carbohydrates in cell recognition: Endogenous lectins. Biol Cell 1994;51:113-294.
6. Gorelik E, Galili U, Raz A. On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis. Cancer Metastasis Rev 2001;20:245-277.
7. Steuer MK, Steuer M, Bonkowsky V, Gabius HJ, Hofstadter F. Characterization of sugar receptor expression by neoglycoproteins in oral and oropharyngeal squamous cell carcinomas. Eur Arch Otorhinolaryngol 1995;252:292-297.
8. Gibbs RV, Lewis JL, Gordon MY. Expression of cell-surface lectins on haemopoietic progenitor cells. Br J Biomed Sci 1995;52:249-256.
9. Cerdan D, Redziniak G, Bourgeois CA, Monsigny M, Kieda C. C32 human melanoma cell endogenous lectins: Characterization and implication in vesicle-mediated melanin transfer to keratinocytes. Exp Cell Res 1992;203:164-173.
10. Cerdan D, Grillon C, Monsigny M, Redziniak G, Kieda C. Human keratinocyte membrane lectins: Characterization and modulation of their expression by cytokines. Biol Cell 1991;73:35-42.
11. Condaminet B, Péguet-Navarro J, Stahl PD, Dalbiez-Gauthier C, Schmitt D, Berthier-Vergnes O. Human epidermal Langerhans cells express the mannose-fucose binding receptor. Eur J Immunol 1998;28:3541-3551.
12. Fajac I, Briand P, Monsigny M, Midoux P. Sugar-mediated uptake of glycosylated polylysines and gene transfer into normal and cystic fibrosis airway epithelial cells. Hum Gene Ther 1999;10:395-406.
13. Choi YH, Liu F, Choi JS, Kim SW, Parks JS. Characterization of a targeted gene carrier, lactose-polyethylene glycol-grafted poly-L-lysine and its complex with plasmid DNA. Hum Gene Ther 1999;10:2657-2665.
14. Remy JS, Kichler A, Mordvinov V, Schuber F, Behr JP. Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: A stage toward artificial viruses. Proc Natl Acad Sci USA 1995;92:1744-1748.
15. Cansell M, Parisel C, Jozefonvicz J, Letourneur D. Heparin encapsulated in liposome inhibits smooth muscle cell growth in vitro. In: Ottenbrite RM, editor. Frontiers in biomedical polymer applications, Vol. 2. Lancaster PA: Technomic; 1999. p 105-114.
16. Cansell M, Parisel C, Jozefonvicz J, Letourneur D. Liposomes coated with chemically modified dextran interact with human endothelial cells. J Biomed Mater Res 1999;44:140-148.
17. Blondin C, Bataille I, Letourneur D. Polysaccharides for vascular cell targeting. Crit Rev Ther Drug Carrier Syst 2000;17:327-375.
18. Letourneur D, Parisel C, Prigent-Richard S, Cansell M. Interactions of functionalized dextran-coated liposomes with vascular smooth muscle cells. J Controlled Release 2000;65:83-91.
19. Betz G, Nowbakht P, Imboden R, Imanidis G. Heparin penetration into and permeation through human skin from aqueous and liposomal formulations in vitro. Int J Pharmaceut 2001;228:147-159.
20. Lestini BJ, Sagnella SM, Xu Z, Shive MS, Richter NJ, Jayaseharan J, Case AJ, Kottke-Marchant K, Anderson JM, Marchant RE. Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery. J Controlled Release 2002;78:235-247.
21. San Antonio JD, Lander AD, Wright TC, Karnovsky MJ. Heparin inhibits the attachment and growth of balb/c-3T3 fibroblasts on collagen substrata. J Cell Physiol 1992;150:8-16.
22. Majack RA, Clowes AW. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J Cell Physiol 1994;118:253-256.
23. Letourneur D, Caleb BL, Castellot JJ. Heparin binding, internalization, and metabolism in vascular smooth muscle cells. I. Upregulation of heparin binding correlates with antiproliferative activity. J Cell Physiol 1995;165:676-686.
24. Stearns NA, Prigent-Richard S, Letourneur D, Castellot JJ. Synthesis and characterization of highly sensitive heparin probes for detection of heparin-binding proteins. Anal Biochem 1997;247:348-356.
25. Prydz K, Dalen KT. Synthesis and sorting of proteoglycans. J Cell Sci 2000;113:193-205.
26. Boyce S, Ham R. Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol 1983;81:33-40.
27. Prigent-Richard S, Cansell M, Vassy J, Viron A, Puvion E, Jozefonvicz J, Letourneur D. Fluorescent and radiolabeling of polysaccharides: Binding and internalization experiments on vascular cells. J Biomed Mater Res 1998;40:275-281.
28. Deux JF, Prigent-Richard S, d'Angelo G, Feldman LJ, Puvion E, Logeart-Avramoglou D, Pelle A, Boudghene FP, Michel JB, Letourneur D. A chemically modified dextran inhibits smooth muscle cell growth in vitro and intimal in stent hyperplasia in vivo. J Vasc Surg 2002;35:973-981.
29. Ferrao AV, Mason RM, The effect of heparin on cell proliferation and type-I collagen synthesis by adult human dermal fibroblasts. Biochim Biophys Acta 1993;1180:225-230.
30. Pillai S, Gilliam L, Conrad HE, Holleran WM. Heparin and its non-anticoagulant analogues inhibit human keratinocyte growth without inducing differentiation. J Invest Dermatol 1994;103:647-650.
31. Wen J, Hsu E, Kenney WC, Philo JS, Morris CF, Arakawa T. Characterization of keratinocyte growth factor binding to heparin and dextran sulfate. Arch Biochem Biophys 1996;332:41-46.
32. Kratz G, Arnander C, Swedenborg J, Back M, Falk C, Gouda I, Larm O. Heparin-chitosan complexes stimulate wound healing in human skin. Scand J Plast Reconstr Hand Surg 1997;31:119-123.
33. Brown MB, Hanpanitcharoen M, Martin GP. An in vitro investigation into the effect of glycosaminoglycans on the skin partitioning and deposition of NSAIDs. Int J Pharmaceut 2001;225:113-121.